Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

by Li, Jingmei, Lei, Jieping, Rudolph, Anja, Moysich, Kirsten Barbara, Rafiq, Sajjad, Behrens, Sabine, Goode, Ellen L., Pharoah, Paul D P, Seibold, Petra, Fasching, Peter Andreas Ndreas, Andrulis, Irene Louise Irene L, Kristensen V.N., Couch F.J., Hamann U., Hooning M.J., Nevanlinna H., Eilber U., Bolla M.K., Dennis J., Wang Q., Lindblom A., Mannermaa A., Lambrechts D., Garcia-Closas M., Hall P., Chenevix-Trench G., Shah M., Luben R., Haeberle L., Ekici A.B., Beckmann M.W., Knight J.A., Glendon G., Tchatchou S., Alnaes G.I.G., Borresen-Dale A.-L., Nord S., Olson J.E., Hallberg E., Vachon C., Torres D., Ulmer H.-U., Rudiger T., Jager A., van Deurzen C.H.M., Tilanus-Linthorst M.M.A., Muranen T.A., Aittomaki K., Blomqvist C., Margolin S., Kosma V.-M., Hartikainen J.M., Kataja V., Hatse S., Wildiers H., Smeets A., Figueroa J., Chanock S.J., Lissowska J.,Humphreys K., Phillips K.-A., Linn S., Cornelissen S., van den Broek S.A.J., Kang D., Choi J.-Y., Park S.K., Yoo K.-Y., Hsiung C.-N., Wu P.-E., Hou M.-F., Shen C.-Y., Teo S.H., Taib N.A.M., Yip C.H., Ho G.F., Matsuo K., Ito H., Iwata H., Tajima K., Dunning A.M., Benitez J., Czene K., Sucheston L.E., Maishman T., Tapper W.J., Eccles D., Easton D.F., Schmidt M.K., Chang-Claude J.
Published 2016